JPMORGAN CHASE & CO - 30 Jun 2025 SCHEDULE 13G Report for Karyopharm Therapeutics Inc. Common Stock, $0.0001 par value (KPTI)

Filing Manager: JPMORGAN CHASE & CO
Reporting Manager: JPMORGAN CHASE & CO.
Security: Karyopharm Therapeutics Inc. Common Stock, $0.0001 par value
Symbol: KPTI
Shares outstanding: 8,662,231 shares
Disclosed Ownership: 450,436 shares
Ownership: 5.2%
Form type: SCHEDULE 13G
Filing time: 16 Jul 2025, 09:34:25 UTC
Date of event: 30 Jun 2025
Next filing: 17 Oct 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
JPMORGAN CHASE & CO.	5.2%	450,436	450,436	0	Rachel Tsvaygoft	Vice President